GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » Additional Paid-In Capital

Polaris AI Pharma (XKRX:041910) Additional Paid-In Capital : ₩39,839 Mil(As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Polaris AI Pharma Additional Paid-In Capital?


Polaris AI Pharma's quarterly additional paid-in capital increased from Sep. 2024 (₩35,241 Mil) to Dec. 2024 (₩39,839 Mil) but then stayed the same from Dec. 2024 (₩39,839 Mil) to Mar. 2025 (₩39,839 Mil).

Polaris AI Pharma's annual additional paid-in capital stayed the same from Dec. 2022 (₩30,491 Mil) to Dec. 2023 (₩30,491 Mil) but then increased from Dec. 2023 (₩30,491 Mil) to Dec. 2024 (₩39,839 Mil).

Polaris AI Pharma Additional Paid-In Capital Historical Data

The historical data trend for Polaris AI Pharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris AI Pharma Additional Paid-In Capital Chart

Polaris AI Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30,491.27 30,491.27 30,491.27 30,491.27 39,839.38

Polaris AI Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30,491.27 35,241.04 35,241.04 39,839.38 39,839.38

Polaris AI Pharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Polaris AI Pharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Polaris AI Pharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Polaris AI Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » Additional Paid-In Capital
Comparable Companies
XKRX:009300 XKRX:204840 XKRX:054670 XKRX:072020 XKRX:066700 XKRX:002720 XKRX:131030 XKRX:002800 XKRX:004310 XKRX:229500 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
25 Balangongdan-ro, Hyangnam-eup, Gyeonggi-do, Hwaseong-si, KOR
Website
https://www.polarisaipharma.com
Polaris AI Pharma Corp is engaged in the production of raw pharmaceutical ingredients. It focuses on generic drugs and produces about 40 types of raw medicines, including asthma treatments, gastric ulcer treatments, and alcohol dependence treatments, and supplies them domestically and internationally.

Polaris AI Pharma Headlines

No Headlines